Stereotaxis, Inc.
STXSStereotaxis, Inc. in brief
Stereotaxis, Inc. is a listed company in the Medical Instruments industry, based in St.Louis, Missouri, USA. It was founded in 1990. Its market value was $92 M on 30 October 2026, which makes it the 19,063rd largest listed company in the world and the 3,558th largest in the USA on this site. In the year to December 2025 it had sales of $32 M and a net loss of $22 M. It employs about 131 people and David Fischel is its chief executive. Its largest product and service lines by sales in 2025 were Disposables Service and Accessories (68%) and Systems (32%). By market, the largest shares of its 2025 sales came from USA (40%). Its shares trade under the symbol STXS (NYSE).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Stereotaxis, Inc.
These statements relate to future events or future financial performance, and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “could”, “expects”, “plans”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, “potential”, or “continue”, or the negative of such terms or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. These statements are only predictions.
From the company's annual report filed with the US SEC: read the report
Stereotaxis, Inc. timeline
- 1990
- 🏁· approximateFounded
- 2004
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2021
- 💰Record revenue of $35 millionFY2021, the highest of the 8 years on record.
Events of Stereotaxis, Inc. from the company record, SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #2,778 (Jan 2020) · #2,986 (Jan 2021) · #3,014 (Jan 2022) · #3,937 (Dec 2022) · #4,026 (Jul 2023) · #3,443 (Jan 2024) · #1,725 (Mar 2026) · #3,278 (Aug 2026) · #3,465 (Oct 2026) · #3,562 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 3.1×
- Price / book
- 6.8×
- Free cash flow yield
- -15.0%
- Net margin (TTM)
- -74.2%
- Operating margin
- -68.3%
- Return on equity
- -165.6%
- Liabilities / assets
- 64.2%
- Net debt
- $-43M
- Revenue growth
- +20.3%
- R&D / revenue
- 29.0%
- Revenue per employee
- $247 K
- Profit per employee
- $-165 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $32M | +20.3% | $-22M | $-22M | -66.8% |
| Dec 2024 | $27M | +0.6% | $-25M | $-24M | -89.3% |
| Dec 2023 | $27M | -4.9% | $-22M | $-21M | -77.4% |
| Dec 2022 | $28M | -19.6% | $-19M | $-18M | -65.0% |
| Dec 2021 | $35M | +31.5% | $-13M | $-11M | -30.6% |
| Dec 2020 | $27M | -7.9% | $-7M | $-7M | -25.0% |
| Dec 2019 | $29M | -1.5% | $-5M | $-5M | -15.9% |
| Dec 2018 | $29M | — | $-2M | $0M | 0.4% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-14M | $0M | $-14M | $-0.25 | — |
| Dec 2024 | $-9M | $0M | $-9M | $-0.30 | — |
| Dec 2023 | $-9M | $0M | $-10M | $-0.27 | — |
| Dec 2022 | $-8M | $2M | $-11M | $-0.26 | — |
| Dec 2021 | $-3M | $1M | $-4M | $-0.16 | — |
| Dec 2020 | $-4M | $0M | $-4M | $-0.11 | — |
| Dec 2019 | $-5M | $0M | $-5M | $-0.10 | — |
| Dec 2018 | $-3M | $0M | $-3M | $-0.03 | — |
Quarterly results
Latest quarter to Jun 2026: revenue $8M (-12.8% on a year earlier), net income $-4M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.
SEC filings
- Nov 10, 20268-KCurrent reportMaterial agreement · Results of operations · New financial obligation · Unregistered share sale
- Aug 12, 202610-QQuarterly report · period to Jun 2026
- Aug 11, 20268-KCurrent reportResults of operations
- Jul 16, 20268-KCurrent reportOther events
- Jul 9, 20268-KCurrent reportUnregistered share sale · Regulation FD disclosure · Other events
- May 15, 20268-KCurrent reportShareholder vote
- May 13, 202610-QQuarterly report · period to Mar 2026
- May 12, 20268-KCurrent reportResults of operations
- Apr 15, 20268-KCurrent reportMaterial agreement · Unregistered share sale · Regulation FD disclosure
- Apr 3, 202610-K/AAnnual report (amended) · period to Dec 2025
- Apr 3, 2026DEF 14AProxy statement
- Mar 12, 202610-KAnnual report · period to Dec 2025
Official filings of Stereotaxis, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $32 M
- Operating income
- $-22 M
- Net income
- $-22 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $52 M
- Total liabilities
- $34 M
- Total equity
- $13 M
As of December-2025
Top 100 institutional investors in Stereotaxis, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | DAFNA Capital Management LLC | 13,680,554 | 0 (0.00%) | 13.65% | $17 M | Nov 16, 2026 |
| 2 | BlackRock, Inc. | 4,384,200 | -12,635 (-0.29%) | 4.38% | $5 M | Nov 13, 2026 |
| 3 | Lagoda Investment Management, L.P. | 3,981,900 | -140,700 (-3.41%) | 3.97% | $5 M | Nov 16, 2026 |
| 4 | Vanguard Capital Management LLC | 3,009,889 | -34,931 (-1.15%) | 3.00% | $4 M | Nov 13, 2026 |
| 5 | Arbiter Partners Capital Management LLC | 2,883,856 | -2,883,856 (-50.00%) | 2.88% | $4 M | Nov 12, 2026 |
| 6 | Geode Capital Management, LLC | 1,904,750 | +9,507 (+0.50%) | 1.90% | $2 M | Nov 6, 2026 |
| 7 | Archon Capital Management LLC | 1,226,044 | 0 (0.00%) | 1.22% | $2 M | Nov 16, 2026 |
| 8 | Warberg Asset Management LLC | 1,131,371 | +22,482 (+2.03%) | 1.13% | $1 M | Nov 2, 2026 |
| 9 | State Street Corp | 910,966 | -5,814 (-0.63%) | 0.91% | $1 M | Nov 12, 2026 |
| 10 | Integrity Alliance, LLC. | 699,023 | New | 0.70% | $1 M | Oct 29, 2026 |
| 11 | AlphaCentric Advisors LLC | 600,000 | 0 (0.00%) | 0.60% | $1 M | Nov 3, 2026 |
| 12 | Vanguard Fiduciary Trust Co | 587,476 | -1,634 (-0.28%) | 0.59% | $1 M | Nov 13, 2026 |
| 13 | Northern Trust Corp | 561,854 | +32,159 (+6.07%) | 0.56% | $1 M | Nov 16, 2026 |
| 14 | Bank Julius Baer & Co. Ltd, Zurich | 540,530 | 0 (0.00%) | 0.54% | $1 M | Oct 29, 2026 |
| 15 | Vanguard Portfolio Management LLC | 478,334 | +14,754 (+3.18%) | 0.48% | $1 M | Nov 13, 2026 |
| 16 | Sequoia Financial Advisors, LLC | 380,243 | -1,112 (-0.29%) | 0.38% | $0 M | Nov 13, 2026 |
| 17 | UBS Group AG | 372,228 | +120,895 (+48.10%) | 0.37% | $0 M | Nov 10, 2026 |
| 18 | Goldman Sachs Group Inc | 329,420 | +94,449 (+40.20%) | 0.33% | $0 M | Nov 16, 2026 |
| 19 | Bank of New York Mellon Corp | 310,068 | +98,427 (+46.51%) | 0.31% | $0 M | Nov 5, 2026 |
| 20 | Prescott Group Capital Management, L.L.C. | 237,495 | 0 (0.00%) | 0.24% | $0 M | Oct 30, 2026 |
| 21 | Independent Advisor Alliance | 212,985 | +4,500 (+2.16%) | 0.21% | $0 M | Nov 10, 2026 |
| 22 | Charles Schwab Investment Management Inc | 174,215 | +30,049 (+20.84%) | 0.17% | $0 M | Nov 16, 2026 |
| 23 | Royal Bank Of Canada | 173,757 | +8,394 (+5.08%) | 0.17% | $0 M | Nov 16, 2026 |
| 24 | Price T Rowe Associates Inc /MD/ | 172,867 | +32,165 (+22.86%) | 0.17% | $0 M | Nov 16, 2026 |
| 25 | Morgan Stanley | 172,743 | -159,364 (-47.99%) | 0.17% | $0 M | Nov 13, 2026 |
Show all 100: investors 26 to 100
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Bank Of America Corp /de/ | 145,081 | +27,763 (+23.66%) | 0.14% | $0 M | Nov 16, 2026 |
| 27 | Bridgeway Capital Management, LLC | 139,330 | -34,445 (-19.82%) | 0.14% | $0 M | Nov 16, 2026 |
| 28 | GMT Capital Corp | 126,581 | 0 (0.00%) | 0.13% | $0 M | Nov 16, 2026 |
| 29 | Empowered Funds, LLC | 125,030 | New | 0.12% | $0 M | Nov 13, 2026 |
| 30 | Nuveen, LLC | 113,836 | +39,846 (+53.85%) | 0.11% | $0 M | Nov 10, 2026 |
| 31 | Barclays PLC | 82,504 | +15,564 (+23.25%) | 0.08% | $0 M | Nov 6, 2026 |
| 32 | Leonteq Securities AG | 74,994 | 0 (0.00%) | 0.07% | $0 M | Oct 29, 2026 |
| 33 | AQR Capital Management LLC | 70,582 | -126,040 (-64.10%) | 0.07% | $0 M | Nov 16, 2026 |
| 34 | HSBC Holdings PLC | 68,605 | 0 (0.00%) | 0.07% | $0 M | Nov 16, 2026 |
| 35 | Susquehanna International Group, LLP | 60,748 | +10,189 (+20.15%) | 0.06% | $0 M | Nov 16, 2026 |
| 36 | Deutsche Bank AG\ | 59,338 | -8,199 (-12.14%) | 0.06% | $0 M | Nov 6, 2026 |
| 37 | R Squared Ltd | 49,784 | +36,057 (+262.67%) | 0.05% | $0 M | Nov 6, 2026 |
| 38 | Quadrature Capital Ltd | 49,267 | +38,561 (+360.18%) | 0.05% | $0 M | Nov 13, 2026 |
| 39 | Cetera Investment Advisers | 48,813 | New | 0.05% | $0 M | Nov 13, 2026 |
| 40 | Invesco Ltd. | 47,941 | +9,371 (+24.30%) | 0.05% | $0 M | Nov 12, 2026 |
| 41 | Rhumbline Advisers | 45,308 | -84,734 (-65.16%) | 0.05% | $0 M | Nov 10, 2026 |
| 42 | TCFG Investment Advisors, LLC | 41,015 | -28,000 (-40.57%) | 0.04% | $0 M | Oct 20, 2026 |
| 43 | Verition Fund Management LLC | 35,000 | 0 (0.00%) | 0.03% | $0 M | Nov 13, 2026 |
| 44 | Vanguard Global Advisers, LLC | 34,663 | +271 (+0.79%) | 0.03% | $0 M | Nov 13, 2026 |
| 45 | Jpmorgan Chase & Co | 34,327 | +4,030 (+13.30%) | 0.03% | $0 M | Nov 12, 2026 |
| 46 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 33,068 | +1,675 (+5.34%) | 0.03% | $0 M | Nov 16, 2026 |
| 47 | Cherry Creek Investment Advisors, Inc. | 28,027 | -14,575 (-34.21%) | 0.03% | $0 M | Oct 14, 2026 |
| 48 | Thompson Davis & Co., Inc. | 27,999 | 0 (0.00%) | 0.03% | $0 M | Nov 5, 2026 |
| 49 | Forum Financial Management, LP | 26,618 | +100 (+0.38%) | 0.03% | $0 M | Oct 16, 2026 |
| 50 | Russell Investments Group, Ltd. | 26,411 | +9,003 (+51.72%) | 0.03% | $0 M | Nov 6, 2026 |
| 51 | Vanguard Personalized Indexing Management, LLC | 26,145 | New | 0.03% | $0 M | Nov 16, 2026 |
| 52 | Wells Fargo & Company/mn | 22,720 | -39,471 (-63.47%) | 0.02% | $0 M | Nov 16, 2026 |
| 53 | Summit Asset Management, LLC | 22,500 | 0 (0.00%) | 0.02% | $0 M | Nov 5, 2026 |
| 54 | Alliancebernstein L.P. | 21,780 | 0 (0.00%) | 0.02% | $0 M | Nov 16, 2026 |
| 55 | Choreo, LLC | 21,688 | +8,630 (+66.09%) | 0.02% | $0 M | Oct 28, 2026 |
| 56 | Wealthspire Advisors, LLC | 20,000 | -4,000 (-16.67%) | 0.02% | $0 M | Nov 13, 2026 |
| 57 | Z3 Capital Partners, LLC | 20,000 | -5,000 (-20.00%) | 0.02% | $0 M | Nov 10, 2026 |
| 58 | BNP Paribas Financial Markets | 19,620 | +8,467 (+75.92%) | 0.02% | $0 M | Nov 12, 2026 |
| 59 | Raymond James Financial Inc | 19,134 | +101 (+0.53%) | 0.02% | $0 M | Nov 12, 2026 |
| 60 | PNC Financial Services Group, Inc. | 18,611 | +1,307 (+7.55%) | 0.02% | $0 M | Nov 6, 2026 |
| 61 | Police & Firemen's Retirement System of New Jersey | 17,997 | 0 (0.00%) | 0.02% | $0 M | Nov 9, 2026 |
| 62 | Investors Research Corp | 17,950 | 0 (0.00%) | 0.02% | $0 M | Oct 7, 2026 |
| 63 | Squarepoint Ops LLC | 14,503 | New | 0.01% | $0 M | Nov 9, 2026 |
| 64 | LPL Financial LLC | 13,930 | +3,000 (+27.45%) | 0.01% | $0 M | Nov 6, 2026 |
| 65 | WealthPLAN Partners, LLC | 13,665 | 0 (0.00%) | 0.01% | $0 M | Oct 15, 2026 |
| 66 | Envestnet Asset Management Inc | 12,291 | -79,287 (-86.58%) | 0.01% | $0 M | Nov 16, 2026 |
| 67 | Renaissance Technologies LLC | 10,900 | -4,500 (-29.22%) | 0.01% | $0 M | Nov 12, 2026 |
| 68 | Benin Management CORP | 10,500 | 0 (0.00%) | 0.01% | $0 M | Oct 22, 2026 |
| 69 | Cerity Partners LLC | 10,369 | -3,203 (-23.60%) | 0.01% | $0 M | Nov 13, 2026 |
| 70 | FMR LLC | 10,293 | -14,507 (-58.50%) | 0.01% | $0 M | Nov 10, 2026 |
| 71 | Roble, Belko & Company, Inc | 10,000 | 0 (0.00%) | 0.01% | $0 M | Nov 9, 2026 |
| 72 | Pasadena Private Wealth, LLC | 10,000 | 0 (0.00%) | 0.01% | $0 M | Nov 10, 2026 |
| 73 | Tower Research Capital LLC (TRC) | 8,815 | -2,778 (-23.96%) | 0.01% | $0 M | Nov 16, 2026 |
| 74 | Legal & General Group Plc | 7,819 | 0 (0.00%) | 0.01% | $0 M | Nov 16, 2026 |
| 75 | New York State Common Retirement Fund | 7,600 | 0 (0.00%) | 0.01% | $0 M | Nov 17, 2026 |
| 76 | Global Retirement Partners, LLC | 7,562 | New | 0.01% | $0 M | Nov 10, 2026 |
| 77 | Rockefeller Capital Management L.P. | 5,950 | +1,000 (+20.20%) | 0.01% | $0 M | Nov 13, 2026 |
| 78 | Ameritas Investment Partners, Inc. | 5,370 | 0 (0.00%) | 0.01% | $0 M | Nov 13, 2026 |
| 79 | Farther Finance Advisors, LLC | 4,157 | +60 (+1.46%) | 0.00% | $0 M | Oct 8, 2026 |
| 80 | Citigroup Inc | 3,379 | -28,619 (-89.44%) | 0.00% | $0 M | Nov 4, 2026 |
| 81 | Group One Trading LLC | 2,936 | 0 (0.00%) | 0.00% | $0 M | Nov 10, 2026 |
| 82 | Nisa Investment Advisors, LLC | 2,794 | 0 (0.00%) | 0.00% | $0 M | Oct 20, 2026 |
| 83 | Bell Investment Advisors, Inc | 2,652 | New | 0.00% | $0 M | Oct 29, 2026 |
| 84 | Smartleaf Asset Management LLC | 2,367 | -1,113 (-31.98%) | 0.00% | $0 M | Nov 10, 2026 |
| 85 | Sterling Capital Management LLC | 2,236 | +2,052 (+1115.22%) | 0.00% | $0 M | Oct 22, 2026 |
| 86 | Bare Financial Services, Inc | 2,214 | New | 0.00% | $0 M | Nov 4, 2026 |
| 87 | Osaic Holdings, Inc. | 1,889 | +629 (+49.92%) | 0.00% | $0 M | Nov 12, 2026 |
| 88 | Hickory Point Bank & Trust | 1,500 | 0 (0.00%) | 0.00% | $0 M | Oct 1, 2026 |
| 89 | Simplex Trading, LLC | 1,364 | -1,516 (-52.64%) | 0.00% | $0 M | Nov 4, 2026 |
| 90 | Avion Wealth | 1,000 | 0 (0.00%) | 0.00% | $0 M | Nov 4, 2026 |
| 91 | California State Teachers Retirement System | 871 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
| 92 | GAMMA Investing LLC | 550 | New | 0.00% | $0 M | Oct 8, 2026 |
| 93 | Arax Advisory Partners | 480 | -940 (-66.20%) | 0.00% | $0 M | Nov 12, 2026 |
| 94 | Allworth Financial LP | 205 | -385 (-65.25%) | 0.00% | $0 M | Nov 17, 2026 |
| 95 | EverSource Wealth Advisors, LLC | 177 | -98 (-35.64%) | 0.00% | $0 M | Nov 4, 2026 |
| 96 | James T. Borello RIA | 132 | New | 0.00% | $0 M | Oct 16, 2026 |
| 97 | Clark Wealth Partners | 100 | 0 (0.00%) | 0.00% | $0 M | Oct 19, 2026 |
| 98 | Fortitude Family Office, LLC | 66 | -18 (-21.43%) | 0.00% | $0 M | Oct 14, 2026 |
| 99 | IFP Advisors, Inc | 24 | +10 (+71.43%) | 0.00% | $0 M | Oct 16, 2026 |
| 100 | Essential Partners LLC | 9 | -191 (-95.50%) | 0.00% | $0 M | Oct 14, 2026 |
Mutual funds holding Stereotaxis, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 1.98 M | $3 M | 2.0% | <0.01% | +3.6% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 1.63 M | $3 M | 1.6% | <0.01% | +13% | Jun 30, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 985,512 | $2 M | 0.98% | <0.01% | −2.2% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 640,255 | $1 M | 0.64% | <0.01% | +41% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 733,836 | $1 M | 0.73% | <0.01% | +21% | Jul 31, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 437,373 | $1 M | 0.44% | <0.01% | −0.8% | May 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 318,322 | $1 M | 0.32% | <0.01% | +6.5% | May 31, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 228,492 | $0 M | 0.23% | 0.03% | +46% | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 147,741 | $0 M | 0.15% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 124,229 | $0 M | 0.12% | <0.01% | +6.6% | May 31, 2026 |
| 🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC | 127,100 | $0 M | 0.13% | 0.15% | no change | Jun 30, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 164,422 | $0 M | 0.16% | <0.01% | +27% | Jul 31, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 109,607 | $0 M | 0.11% | <0.01% | +71% | Jun 30, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 100,304 | $0 M | 0.10% | <0.01% | +12% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC | 63,199 | $0 M | 0.06% | <0.01% | +42% | Jun 30, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 63,157 | $0 M | 0.06% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 52,938 | $0 M | 0.05% | <0.01% | +3.2% | May 31, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 73,990 | $0 M | 0.07% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 43,500 | $0 M | 0.04% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 40,691 | $0 M | 0.04% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 34,931 | $0 M | 0.03% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC | 43,108 | $0 M | 0.04% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 23,285 | $0 M | 0.02% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc. | 26,120 | $0 M | 0.03% | <0.01% | −27% | Jun 30, 2026 |
| 🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC | 32,568 | $0 M | 0.03% | <0.01% | +22% | Jul 31, 2026 |
| 🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC | 28,245 | $0 M | 0.03% | <0.01% | −1.9% | Jul 31, 2026 |
| 🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 20,200 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 16,233 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 15,379 | $0 M | 0.02% | 0.01% | +39% | Jun 30, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 13,764 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 13,190 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 12,390 | $0 M | 0.01% | <0.01% | +48% | Jun 30, 2026 |
| 🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC | 14,560 | $0 M | 0.01% | <0.01% | +18% | Jul 31, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC | 9,899 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 9,390 | $0 M | <0.01% | <0.01% | +74% | Jun 30, 2026 |
| 🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc. | 8,864 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 7,720 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc. | 6,965 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc. | 9,499 | $0 M | <0.01% | <0.01% | +7.1% | Jul 31, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 6,854 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC | 9,381 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 6,276 | $0 M | <0.01% | <0.01% | +67% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc. | 5,369 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC | 5,944 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management | 5,370 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC | 6,634 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC | 4,743 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc. | 3,268 | $0 M | <0.01% | <0.01% | +4.5% | May 31, 2026 |
| 🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS | 4,929 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC | 2,925 | $0 M | <0.01% | <0.01% | +11% | May 31, 2026 |
| 🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC | 2,874 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC | 4,266 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC | 2,311 | $0 M | <0.01% | <0.01% | −38% | May 31, 2026 |
| 🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC | 2,288 | $0 M | <0.01% | <0.01% | −39% | May 31, 2026 |
| 🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC | 1,846 | $0 M | <0.01% | <0.01% | −5.0% | May 31, 2026 |
| 🇺🇸 VIP Total Market Index PortfolioFidelity Management & Research Company LLC | 2,064 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc. | 1,739 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC | 853 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 58 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Stereotaxis, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Arun Swarup MenawatDirector | Buy | +121,561 | $0.823 | $100 K | 1.16 M | Form 4 |
| filed | David BenferDirector | Buyindirect | +30,000 | $0.829 | $25 K | 240,255 | Form 4 |
| filed | Paul J. IsaacDirector | Buyindirect | +300 | $0.800 | $240 | 2.80 M | Form 4 |
| filed | Paul J. IsaacDirector | Buyindirect | +13,000 | $0.820 | $11 K | 2.80 M | Form 4 |
| filed | Nathan FischelDirector, 10% owner | Grant or award | +43,103 | — | — | 720,775 | Form 4 |
| filed | Arun Swarup MenawatDirector | Grant or award | +43,103 | — | — | 1.04 M | Form 4 |
| filed | Myriam CuretDirector | Grant or award | +43,103 | — | — | 435,161 | Form 4 |
| filed | Ross B. LevinDirector | Grant or award | +43,103 | — | — | 621,248 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Stereotaxis, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Stock splits: 1-for-10 reverse split
Fails to deliver
- : 25,500 shares at $0.91
- : 1,349 shares at $1.00
- : 258 shares at $0.99
- : 20 shares at $1.05
- : 11 shares at $1.06
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Stereotaxis, Inc. scorecard#
Passes 2 of the 22 checks that could be worked out: strongest in financial health (1 of 3), weakest in valuation (0 of 5). Fiscal year 2025; market cap of Oct 30, 2026.
Valuation0 of 5
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✗Price to book below its peers' median6.8×Price to book 6.8× against Medical Instruments's median of 3.9×.
- ✗Price to sales below its peers' median3.0×Price to sales 3.0× against Medical Instruments's median of 3.0×.
- ✗Free cash flow yield above 5%-15.0%Free cash flow is -15.0% of the market value.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth1 of 6
- ✓Revenue grew in the newest year20.3%Revenue up 20.3% in fiscal 2025.
- ✗Revenue up more than 5% a year over three years4.8%4.8% a year over the three years to fiscal 2025.
- ✗Faster growth over three years than its peers' median4.8%4.8% a year against Medical Instruments's median of 5.0% (37 companies).
- ✗Earnings per share grew in the newest year-0.25 vs -0.30Diluted EPS -0.25 in fiscal 2025 against -0.30 the year before (report's currency).
- ✗Net income higher than five years earlier-$22 M-$22 M in fiscal 2025 against -$7 M in 2020.
- ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2025.
Profitability0 of 5
- ✗Profitable in the newest year-$22 MNet income -$22 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-68.3%-68.3% against Medical Instruments's median of 7.2% (46 companies).
- ✗Return on equity above 15%-221.3%-221.3% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✗Operating margin wider than three years earlier-68.3%-68.3% in fiscal 2025 against -66.7% in 2022.
Financial health1 of 3
- ✓Short-term assets cover short-term liabilities1.5×Current ratio 1.51 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone-14.50Z-score -14.50 (distress zone) for fiscal 2025.
Shareholder returns0 of 3
- ✗Pays a dividendNoNo dividends in fiscal 2025.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year6.8%Diluted shares up 6.8% in fiscal 2025.
- ✗Dividends and buybacks above 3% of the market value0.0%Dividends and buybacks were 0.0% of the market value.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Medical Instruments, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Stereotaxis, Inc.'s statements, beside the median of Medical Instruments.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -68.3% | 7.2% | |
| Net margin | -66.8% | 3.8% | |
| Return on equity | -221.3% | 3.5% | |
| Revenue growth, 3 years a year | 4.8% | 5.0% | |
| Revenue growth | 20.3% | 8.9% | |
| Free cash flow margin | -42.5% | 6.3% |
4of 8on the Piotroski tests of financial strength
- Net loss of $22 million, the 7th loss-making year in a row.
- Free cash flow was negative: -$14 million.
- The share count rose 6.8% in the year.
- Receivables grew 53% while revenue grew 20%: customers are paying later, or sales were booked ahead of cash.
Stereotaxis, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 | FY 2017to Dec 31, 2017 | FY 2016to Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 32+20.3%100% | 27+0.5%100% | 27−4.9%100% | 28−19.6%100% | 35r35+31.5%100% | 27−7.9%100% | 29−1.5%100% | 29−5.8%100% | 31−3.2%100% | 32—100% | |
| Cost of revenue | 15+24.2%47.3% | 12+3.5%45.8% | 12+23.1%44.5% | 9.7−17.9%34.4% | 12r12+53.8%33.7% | 7.7+24.9%28.8% | 6.1+7.3%21.2% | 5.7−46.8%19.5% | 11+42.8%34.5% | 7.5—23.4% | |
| Gross profit | 17+17.0%52.7% | 15−1.8%54.2% | 15−19.5%55.5% | 18−20.5%65.6% | 23r23+22.5%66.3% | 19−16.7%71.2% | 23−3.7%78.8% | 24+15.9%80.5% | 20−17.2%65.5% | 25—76.6% | |
| Research and development | 9.4−3.9%29.0% | 9.8−5.0%36.3% | 10−2.7%38.4% | 11+3.5%37.5% | 10r10+25.3%29.1% | 8.1−9.8%30.6% | 9.0+9.8%31.2% | 8.2+22.6%28.0% | 6.7r4.8+22.2%21.5% | 5.5—17.1% | |
| Selling and marketing | 12+0.6%38.4% | 12−0.0%46.0% | 12+0.4%46.2% | 12+3.2%43.8% | 12r12+6.9%34.1% | 11−12.2%42.0% | 13−1.8%44.1% | 13−4.9%44.2% | 14r13−10.5%43.8% | 15—47.3% | |
| General and administrative | 18+3.8%55.1% | 17+22.4%63.9% | 14−2.2%52.5% | 14+2.8%51.0% | 14r14+120%39.9% | 6.4+9.0%23.9% | 5.8+19.1%20.2% | 4.9−18.0%16.7% | 6.0r8.5−42.2%19.2% | 10—32.2% | |
| Operating expenses | 39−0.4%121% | 39+7.2%146% | 37−1.5%137% | 37+3.1%132% | 36r36+40.7%103% | 26−6.9%96.4% | 28+5.8%95.5% | 26−0.8%88.9% | 26−15.3%84.5% | 31—96.6% | |
| Operating income | −22—−68.3% | −25—−91.9% | −22—−81.6% | −19—−66.7% | −13r−13—−36.8% | −6.7—−25.2% | −4.8—−16.7% | −2.5—−8.4% | −5.9—−19.0% | −6.4—−20.0% | |
| Interest and finance income | — | — | — | — | 0.1—0.3% | — | — | — | — | 0.0—0.0% | |
| Interest expense and finance costs | — | — | — | — | — | — | — | 0.0−90.8%0.1% | 0.2−92.8%0.6% | 2.5r2.5—7.7% | |
| Net interest income | 0.5−32.7%1.4% | 0.7−36.7%2.6% | 1.1+126%4.1% | 0.5—1.7% | −0.0r−0.0−116%−0.0% | 0.1−71.4%0.3% | 0.2—0.8% | −0.0—−0.1% | — | — | |
| Other non-operating income (expense) | 0.0—0.0% | — | 0.0—0.1% | — | — | — | — | 2.6+1122%8.8% | 0.2—0.7% | −2.0—−6.2% | |
| Net income attributable to shareholders | −22—−66.8% | −24—−89.3% | −21—−77.4% | −18—−65.0% | −11r−11—−30.6% | −6.6—−25.0% | −4.6−4032%−15.9% | 0.1—0.4% | −5.9—−18.9% | −5.3—−16.4% | |
| Earnings per share, basic | -0.25—— | -0.30—— | -0.27—— | -0.26—— | -0.16—— | -0.11—— | -0.10—— | -0.03—— | -0.32—— | -0.54—— | |
| Earnings per share, diluted | -0.25—— | -0.30—— | -0.27—— | -0.26—— | -0.16—— | -0.11—— | -0.10—— | -0.03—— | -0.32—— | -0.54—— | |
| Shares, weighted average (basic) | 91+6.8%— | 85+5.6%— | 81+6.1%— | 76+0.7%— | 76+3.9%— | 73+15.4%— | 63+21.1%— | 52+130%— | 23+3.7%— | 22—— | |
| Shares, weighted average (diluted) | 91+6.8%— | 85+5.6%— | 81+6.1%— | 76+0.7%— | 76+3.9%— | 73+15.4%— | 63+21.1%— | 52+130%— | 23+3.7%— | 22—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 13+9.9%25.7% | 12−38.4%26.1% | 20+131%47.3% | 8.6−77.8%16.1% | 39r39−11.8%63.5% | 44+45.6%79.2% | 30+180%69.2% | 11+193%58.3% | 3.7−56.6%34.6% | 8.5—40.5% | |
| Short-term investments | 0—0.0% | 0—0.0% | — | 20—37.2% | — | — | — | — | — | — | |
| Receivables | 5.8+52.9%11.2% | 3.8+0.1%8.2% | 3.8−24.9%9.1% | 5.1−5.8%9.5% | 5.4r5.4+53.8%8.9% | 3.5−34.0%6.3% | 5.3+6.1%12.2% | 5.0+17.1%27.1% | 4.3−8.1%40.2% | 4.7—22.3% | |
| Inventory | 9.6+14.8%18.3% | 8.3−1.1%17.8% | 8.4+7.0%20.1% | 7.9+77.7%14.7% | 4.4r4.4+34.5%7.3% | 3.3+78.4%5.9% | 1.8+55.0%4.2% | 1.2+3.9%6.4% | 1.1−78.7%10.8% | 5.4—25.7% | |
| Other current assets | 0.7−62.2%1.3% | 1.8+173%4.0% | 0.7−49.0%1.6% | 1.3−43.8%2.5% | 2.4r2.4+37.3%3.9% | 1.7+16.7%3.1% | 1.5+52.6%3.4% | 1.0+28.5%5.2% | 0.8−12.3%7.0% | 0.9—4.1% | |
| Current assets | 34+28.0%64.8% | 26−20.5%56.6% | 33−23.1%79.4% | 43−15.8%81.0% | 51r51−2.5%84.3% | 53+35.8%95.1% | 39+116%89.1% | 18+82.1%97.1% | 9.9−49.1%92.5% | 19—92.5% | |
| Property, plant and equipment | 3.0−15.5%5.8% | 3.6+8.1%7.6% | 3.3−13.8%7.9% | 3.8+45.6%7.2% | 2.6r2.6+1249%4.3% | 0.2−22.1%0.4% | 0.3−27.1%0.6% | 0.3−42.0%1.9% | 0.6−45.4%5.6% | 1.1—5.2% | |
| Right-of-use (leased) assets | 4.9−10.4%9.4% | 5.5+10.1%11.7% | 5.0−7.5%11.9% | 5.4−6.1%10.1% | 5.7r5.7+157%9.4% | 2.2−47.8%4.0% | 4.3—9.8% | — | — | — | |
| Goodwill | 3.80.0%7.2% | 3.8—8.1% | — | — | — | — | — | — | — | — | |
| Other intangible assets | 6.4−12.6%12.3% | 7.4—15.7% | — | — | — | — | — | — | 0.2−63.5%1.5% | 0.4—2.1% | |
| Total assets | 52+11.8%100% | 47+11.5%100% | 42−21.5%100% | 53−12.4%100% | 61r61+10.0%100% | 55+27.2%100% | 44+135%100% | 19+73.6%100% | 11−49.1%100% | 21—100% | |
| Accounts payable | 4.8−15.9%9.1% | 5.7+77.7%12.1% | 3.2−2.4%7.6% | 3.3−21.9%6.1% | 4.2r4.2+160%6.9% | 1.6−23.4%2.9% | 2.1+21.6%4.8% | 1.7+4.4%9.3% | 1.7−36.9%15.5% | 2.6—12.5% | |
| Current liabilities | 22+3.5%42.8% | 22+63.1%46.2% | 13−7.3%31.6% | 14+7.8%26.8% | 13r13−2.3%21.7% | 14+11.6%24.5% | 12+19.3%27.9% | 10−66.2%55.1% | 30−15.5%282% | 36—170% | |
| Long-term debt | — | — | — | — | — | 1.0—1.8% | — | — | — | — | |
| Lease liabilities (non-current) | 4.8−11.8%9.2% | 5.4+7.4%11.6% | 5.1−7.8%12.1% | 5.5−6.1%10.3% | 5.8r5.8—9.6% | — | 2.1—4.8% | — | — | — | |
| Total liabilities | 34−5.0%64.2% | 35+76.6%75.5% | 20−7.0%47.7% | 21−0.4%40.2% | 22r22+41.6%35.4% | 15+1.1%27.5% | 15+34.0%34.6% | 11−64.1%60.7% | 31−14.3%293% | 36—174% | |
| Retained earnings | −583—−1116% | −562—−1202% | −538—−1283% | −517—−968% | −499r−499—−818% | −488—−880% | −481—−1104% | −477—−2575% | −477—−4473% | −471—−2248% | |
| Shareholders' equity | 13+122%25.8% | 6.1−62.8%13.0% | 16−38.0%39.0% | 26−22.1%49.3% | 34r34−2.3%55.5% | 35r35+52.1%62.4% | 23+1636%52.2% | 1.3—7.1% | −27—−249% | −21—−102% | |
| Total liabilities and equity | 52+11.8%100% | 47+11.5%100% | 42−21.5%100% | 53−12.4%100% | 61r61+10.0%100% | 55+27.2%100% | 44+135%100% | 19+73.6%100% | 11−49.1%100% | 21—100% | |
| Cash-flow statement | |||||||||||
| Share-based compensation | 9.9−4.0%30.4% | 10−3.4%38.1% | 11+0.4%39.7% | 11+13.0%37.6% | 9.4r9.4+195%26.7% | 3.2+138%11.9% | 1.3+137%4.6% | 0.6−27.0%1.9% | 0.8−43.7%2.5% | 1.4—4.2% | |
| Cash from operating activities | −14—−42.3% | −8.5—−31.6% | −9.1—−34.1% | −8.4—−29.9% | −2.9r−2.9—−8.4% | −3.5—−13.2% | −4.6—−16.0% | −2.5—−8.7% | −4.7—−15.0% | −6.6—−20.4% | |
| Capital expenditure | −0.1—−0.3% | −0.0—−0.1% | −0.4—−1.4% | −2.4—−8.4% | −1.4r−1.4—−4.0% | −0.1—−0.3% | −0.0—−0.1% | −0.3—−0.9% | −0.1—−0.3% | −0.4—−1.3% | |
| Cash from investing activities | −0.1−226%−0.3% | 0.1−99.6%0.3% | 20—73.8% | −22—−78.5% | −1.4r−1.4—−4.0% | −0.1—−0.3% | −0.0—−0.1% | −0.3—−0.9% | −0.1—−0.3% | −0.4—−1.3% | |
| Shares issued | 16+5171%48.4% | 0.3+267%1.1% | 0.1−63.2%0.3% | 0.2−59.8%0.8% | 0.5r0.5−96.4%1.6% | 15−36.8%57.0% | 24+41961%83.1% | 0.1+39.2%0.2% | 0.0−99.8%0.1% | 23—71.5% | |
| Dividends paid | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | — | — | 0—0.0% | 0—0.0% | |
| Cash from financing activities | 15+4871%45.6% | 0.3+267%1.1% | 0.1−63.2%0.3% | 0.2−59.8%0.8% | 0.5r0.5−96.8%1.6% | 17−27.8%65.1% | 24+142%83.1% | 9.9—33.8% | −0.1−101%−0.2% | 9.9—30.7% | |
| Change in cash | 1.0—3.0% | −8.1−176%−30.2% | 11—40.0% | −30—−108% | −3.8r−3.8−128%−10.8% | 14−29.0%51.7% | 19+173%67.1% | 7.1—24.2% | −4.8−266%−15.5% | 2.9—9.0% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Jun 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 | Q3 FY2023to Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 30−5.5%100% | 7.7−12.8%100% | 6.3−15.8%100% | 8.6*+36.3%100% | 7.5−18.8%100% | 8.8+95.4%100% | 7.5+8.6%100% | 6.3*+38.9%100% | 9.2+17.9%100% | 4.5—100% | 6.9—100% | 4.6*—100% | 7.8—100% | |
| Cost of revenue | 13−15.7%44.4% | 3.2−24.5%41.5% | 2.5−26.7%39.7% | 4.3*+38.1%49.9% | 3.4−34.0%45.1% | 4.2+255%48.0% | 3.4+17.0%45.6% | 3.1*+71.0%49.3% | 5.1+36.3%55.4% | 1.2—26.4% | 2.9—42.4% | 1.8*—40.0% | 3.7—48.0% | |
| Gross profit | 17+4.7%55.6% | 4.5−2.0%58.5% | 3.8−6.6%60.3% | 4.3*+34.5%50.1% | 4.1+0.0%54.9% | 4.6+38.2%52.0% | 4.1+2.5%54.4% | 3.2*+17.5%50.7% | 4.1+1.0%44.6% | 3.3—73.6% | 4.0—57.6% | 2.7*—60.0% | 4.1—52.0% | |
| Research and development | 10+7.2%33.4% | 2.4+34.5%31.2% | 2.4+2.0%38.1% | 2.7*−2.9%31.4% | 2.5+3.7%34.1% | 1.8−21.8%20.2% | 2.4+4.8%31.5% | 2.8*+26.1%44.0% | 2.5−8.0%26.7% | 2.3—50.5% | 2.2—32.6% | 2.2*—48.5% | 2.7—34.2% | |
| Selling and marketing | 11−10.0%37.4% | 2.6−20.6%33.8% | 2.6−16.9%41.6% | 3.1*+6.0%35.8% | 2.9−6.9%39.3% | 3.3−1.0%37.2% | 3.1+4.8%42.1% | 2.9*+4.5%46.0% | 3.2+1.8%34.3% | 3.3—73.3% | 3.0—43.6% | 2.8*—61.1% | 3.1—39.7% | |
| General and administrative | 18−1.6%60.5% | 4.1+1.7%53.1% | 4.8+5.9%75.7% | 4.2*−18.7%48.3% | 5.2+7.0%69.4% | 4.0+6.4%45.5% | 4.5+29.7%60.2% | 5.1*+69.0%81.0% | 4.8+23.0%52.6% | 3.8—83.5% | 3.5—50.4% | 3.0*—66.6% | 3.9—50.4% | |
| Operating expenses | 39−0.9%131% | 9.1+5.8%118% | 9.8−2.2%155% | 10.0*−8.0%115% | 11+2.0%143% | 8.6−8.3%97.2% | 10.0+14.7%134% | 11*+34.8%171% | 10+7.7%114% | 9.3—207% | 8.7—127% | 8.0*—176% | 9.7—124% | |
| Operating income | −23—−75.7% | −4.6—−59.6% | −6.0—−95.1% | −5.6*—−65.4% | −6.6—−87.8% | −4.0—−45.2% | −5.9—−79.3% | −7.6*—−120% | −6.3—−69.0% | −6.0—−134% | −4.7—−69.0% | −5.3*—−116% | −5.6—−72.3% | |
| Net interest income | 0.4−16.9%1.4% | 0.1−34.2%1.3% | 0.1+17.9%2.0% | 0.1*+3.5%1.4% | 0.1−39.3%1.2% | 0.2−20.4%1.7% | 0.1−55.6%1.4% | 0.1*−56.3%1.8% | 0.2−44.4%1.6% | 0.2—4.2% | 0.2—3.5% | 0.3*—5.7% | 0.3—3.5% | |
| Other non-operating income (expense) | −0.0—−0.0% | 0*—0.0% | −0.0—−0.1% | 0*—0.0% | 0.0−40.0%0.0% | −0.0—−0.0% | — | — | 0.0—0.1% | −0.0—−0.1% | — | 0.0*—0.1% | 0*—0.0% | |
| Net income attributable to shareholders | −22—−74.2% | −4.5—−58.3% | −5.9—−93.2% | −5.5*—−64.0% | −6.5—−86.6% | −3.8—−43.5% | −5.8—−77.9% | −7.5*—−119% | −6.2—−67.3% | −5.8—−130% | −4.5—−65.5% | −5.0*—−110% | −5.4—−68.8% | |
| Earnings per share, basic | — | -0.05—— | -0.06—— | — | -0.07—— | -0.05—— | -0.07—— | — | -0.08—— | -0.07—— | -0.06—— | — | -0.07—— | |
| Earnings per share, diluted | — | -0.05—— | -0.06—— | — | -0.07—— | -0.05—— | -0.07—— | — | -0.08—— | -0.07—— | -0.06—— | — | -0.07—— | |
| Shares, weighted average (basic) | 100+13.7%— | 100+13.7%— | 99+12.7%— | — | 92+7.2%— | 88+4.0%— | 88+5.1%— | — | 86+4.1%— | 85—— | 83—— | — | 82—— | |
| Shares, weighted average (diluted) | 100+13.7%— | 100+13.7%— | 99+12.7%— | — | 92+7.2%— | 88+4.0%— | 88+5.1%— | — | 86+4.1%— | 85—— | 83—— | — | 82—— | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 10—18.9% | 10+50.6%18.9% | 15+37.9%27.1% | 13+9.9%25.7% | 11−1.5%23.0% | 7.0−52.6%16.9% | 11−39.9%23.2% | 12−38.4%26.1% | 11−51.8%20.9% | 15—40.8% | 18—44.7% | 20—47.3% | 22—49.6% | |
| Short-term investments | 0—0.0% | 0—0.0% | — | 0—0.0% | 0—0.0% | — | — | 0—0.0% | — | — | — | — | — | |
| Receivables | 7.5—13.6% | 7.5+71.8%13.6% | 5.3+22.6%9.8% | 5.8+52.9%11.2% | 5.3−32.7%11.7% | 4.4+57.9%10.7% | 4.3+9.4%9.5% | 3.8+0.1%8.2% | 7.9+51.0%15.6% | 2.8—7.7% | 4.0—10.0% | 3.8—9.1% | 5.2—11.8% | |
| Inventory | 13—22.5% | 13+30.3%22.5% | 10+7.0%19.4% | 9.6+14.8%18.3% | 10+12.6%22.3% | 9.6+3.5%23.3% | 9.8+18.9%21.5% | 8.3−1.1%17.8% | 9.0+32.7%17.7% | 9.3—25.8% | 8.3—20.9% | 8.4—20.1% | 6.8—15.2% | |
| Other current assets | 1.1—2.0% | 1.1+18.7%2.0% | 1.3+19.2%2.4% | 0.7−62.2%1.3% | 0.7−22.1%1.5% | 0.9+11.2%2.3% | 1.1+28.8%2.4% | 1.8+173%4.0% | 0.9+1.6%1.7% | 0.8—2.3% | 0.8—2.1% | 0.7—1.6% | 0.9—1.9% | |
| Current assets | 38—68.3% | 38+73.4%68.3% | 36+39.0%66.7% | 34+28.0%64.8% | 27−7.5%58.5% | 22−22.0%53.2% | 26−17.0%56.7% | 26−20.5%56.6% | 29−18.9%56.6% | 28—77.9% | 31—79.1% | 33—79.4% | 36—79.8% | |
| Property, plant and equipment | 2.9—5.2% | 2.9−12.3%5.2% | 3.0−14.1%5.5% | 3.0−15.5%5.8% | 3.2−15.5%6.9% | 3.3+7.4%8.0% | 3.4+8.8%7.5% | 3.6+8.1%7.6% | 3.7+8.4%7.3% | 3.1—8.5% | 3.2—8.0% | 3.3—7.9% | 3.4—7.7% | |
| Right-of-use (leased) assets | 4.7—8.4% | 4.7−10.5%8.4% | 4.8−10.9%8.8% | 4.9−10.4%9.4% | 5.1+406%11.1% | 5.2+9.2%12.6% | 5.3+9.6%11.7% | 5.5+10.1%11.7% | 1.0r5.6−80.3%2.0% | 4.8—13.2% | 4.9—12.4% | 5.0—11.9% | 5.1—11.4% | |
| Goodwill | 3.8—6.8% | 3.80.0%6.8% | 3.80.0%7.0% | 3.80.0%7.2% | 3.8−16.2%8.3% | 3.8—9.1% | 3.8—8.2% | 3.8—8.1% | 4.5—8.8% | — | — | — | — | |
| Other intangible assets | 6.0—10.7% | 6.0−13.7%10.7% | 6.2−13.3%11.5% | 6.4−12.6%12.3% | 6.7−18.3%14.6% | 6.9—16.8% | 7.1—15.6% | 7.4—15.7% | 8.2—16.0% | — | — | — | — | |
| Total assets | 56—100% | 56+35.0%100% | 54+18.2%100% | 52+11.8%100% | 46−10.5%100% | 41+14.3%100% | 46+15.8%100% | 47+11.5%100% | 51+14.4%100% | 36—100% | 39—100% | 42—100% | 45—100% | |
| Accounts payable | 6.9—12.4% | 6.9+2.0%12.4% | 4.8−26.3%8.9% | 4.8−15.9%9.1% | 4.7−26.9%10.3% | 6.7+62.3%16.3% | 6.5+97.9%14.3% | 5.7+77.7%12.1% | 6.4+97.4%12.6% | 4.1—11.5% | 3.3—8.4% | 3.2—7.6% | 3.2—7.3% | |
| Current liabilities | 27—48.2% | 27+29.2%48.2% | 23−4.7%42.7% | 22+3.5%42.8% | 20−1.7%44.7% | 21+69.3%50.4% | 24+88.5%53.0% | 22+63.1%46.2% | 21+59.0%40.7% | 12—34.0% | 13—32.6% | 13—31.6% | 13—29.3% | |
| Lease liabilities (non-current) | 4.5—8.1% | 4.5−12.5%8.1% | 4.6−12.5%8.5% | 4.8−11.8%9.2% | 5.0−11.2%10.9% | 5.1+6.2%12.4% | 5.3+6.8%11.6% | 5.4+7.4%11.6% | 5.6+7.9%11.0% | 4.8—13.4% | 4.9—12.5% | 5.1—12.1% | 5.2—11.6% | |
| Total liabilities | 38—68.6% | 38+10.7%68.6% | 34−8.3%63.7% | 34−5.0%64.2% | 34−1.9%74.7% | 34+78.8%83.6% | 38+93.2%82.1% | 35+76.6%75.5% | 35+71.6%68.1% | 19—53.5% | 19—49.2% | 20—47.7% | 20—45.4% | |
| Retained earnings | −594—−1068% | −594—−1068% | −589—−1091% | −583—−1116% | −578—−1268% | −571—−1388% | −568—−1242% | −562—−1202% | −554—−1088% | −548—−1522% | −542—−1374% | −538—−1283% | −533—−1196% | |
| Shareholders' equity | 12—22.0% | 12+741%22.0% | 14+399%26.6% | 13+122%25.8% | 6.3−42.1%13.7% | 1.5−87.2%3.5% | 2.9−80.2%6.3% | 6.1−62.8%13.0% | 11−42.2%21.2% | 11—31.5% | 15—36.9% | 16—39.0% | 19—42.0% | |
| Total liabilities and equity | 56—100% | 56+35.0%100% | 54+18.2%100% | 52+11.8%100% | 46−10.5%100% | 41+14.3%100% | 46+15.8%100% | 47+11.5%100% | 51+14.4%100% | 36—100% | 39—100% | 42—100% | 45—100% | |
| Cash-flow statement | ||||||||||||||
| Share-based compensation | 8.7−13.6%28.8% | 1.6*−32.1%21.0% | 2.1−16.8%33.5% | 2.4*−4.6%28.3% | 2.5*−2.6%33.5% | 2.4*−6.7%26.9% | 2.5−2.1%33.9% | 2.6*−2.7%40.5% | 2.6*−3.9%27.9% | 2.5*—56.4% | 2.6—37.6% | 2.6*—57.7% | 2.7*—34.3% | |
| Cash from operating activities | −15—−50.9% | −3.7*—−47.9% | −3.4—−54.7% | −4.0*−414%−45.9% | −4.2*—−56.3% | −3.7*—−42.4% | −1.8—−23.8% | 1.3*—20.0% | −4.3*—−47.1% | −3.1*—−68.6% | −2.3—−34.1% | −2.4*—−53.4% | −1.0*—−12.4% | |
| Capital expenditure | −0.2—−0.7% | −0.1*—−0.8% | −0.1—−1.3% | −0.1*—−0.8% | 0*—0.0% | — | — | −0.0*—−0.0% | −0.0*—−0.1% | — | — | 0*—0.0% | −0.0*—−0.1% | |
| Cash from investing activities | −1.3—−4.3% | −1.1*—−14.9% | −0.1—−1.3% | −0.1*—−0.8% | 0*−100%0.0% | — | — | −0.0*—−0.0% | 0.1*—1.1% | — | — | 0*—0.0% | −0.0*—−0.1% | |
| Shares issued | 21+6855%70.6% | 0.8*+2168%10.1% | 4.9+15066%77.1% | 7.8*+4835%90.8% | 7.7*+9579%104% | 0.0*+21.4%0.4% | 0.0+6.7%0.4% | 0.2*+512%2.5% | 0.1*+220%0.9% | 0.0*—0.6% | 0.0—0.4% | 0.0*—0.6% | 0.0*—0.3% | |
| Dividends paid | 0—0.0% | 0*—0.0% | 0—0.0% | 0*—0.0% | 0*—0.0% | 0*—0.0% | 0—0.0% | 0*—0.0% | 0*—0.0% | 0*—0.0% | 0—0.0% | 0*—0.0% | 0*—0.0% | |
| Cash from financing activities | 20+6493%66.9% | 0.7*+1944%9.1% | 4.7+14638%75.0% | 7.0*+4274%80.5% | 7.7*+9579%104% | 0.0*+21.4%0.4% | 0.0+6.7%0.4% | 0.2*+512%2.5% | 0.1*+220%0.9% | 0.0*—0.6% | 0.0—0.4% | 0.0*—0.6% | 0.0*—0.3% | |
| Change in cash | 3.5—11.7% | −4.1*—−53.8% | 1.2—19.0% | 2.9*+105%33.7% | 3.5*—47.4% | −3.7*—−42.3% | −1.7—−23.4% | 1.4*—22.4% | −4.2*—−45.1% | −3.1*—−68.5% | −2.3—−33.7% | −2.4*—−52.9% | −1.0*—−12.2% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Jun 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Stereotaxis, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- Disposables Service and Accessories$22 M68%+21%
- Systems$10 M32%+18%
Countries and regions
- Non-US(total)$20 M60%+45%
- 🇺🇸 USA$13 M40%-4.2%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Executive pay at Stereotaxis, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025David Fischel | $64 K | −$2.0 M | $326 K | $111 |
| 2024David Fischel | $62 K | $3.7 M | $340 K | $112 |
| 2023David Fischel | $62 K | −$4.3 M | $324 K | $85 |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at Stereotaxis, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Directors and officers 1 · Material agreement 5 · New debt 1 · Unregistered share sale 5 · Shareholder vote 3 · Results announced 14
| Filed | What happened | Filing |
|---|---|---|
| Material agreementNew debtUnregistered share saleResults announced | 8-K | |
| Results announced | 8-K | |
| Unregistered share sale | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Unregistered share sale | 8-K | |
| Directors and officers | 8-K | |
| Material agreementUnregistered share saleShareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 10, 2026
Acquisitions and funding#
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jul 2024 | $3 M | Private placement after listing | $2 to $10 million | 1 | equity | SEC |
| Aug 2019 | $25 M | Private placement after listing | $10 to $50 million | 6 | equity | SEC |
| Sep 2016 | $24 M | Private placement after listing | $10 to $50 million | 12 | equity, options | SEC |
| May 2012 | $8 M | Private placement after listing | $2 to $10 million | 9 | debt, options | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
H-1B hiring at Stereotaxis, Inc.#
1 labor condition applications certified in fiscal 2022 for 1 positions, at a median wage of $120 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Sr. Principal Electrical EngineerElectrical Engineers | 1 | $120 K |
Where: St. Louis, MO 1
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Stereotaxis, Inc.
How Stereotaxis, Inc. compares in Medical Instruments
- Market cap$92 M · higher than 16% of 116
- Revenue$32 M · higher than 12% of 120
- Net margin-74.2% · higher than 4% of 114
- Revenue growth20.3% · higher than 81% of 49
- Price / sales3.0× · lower than 50% of 85
- Price / book6.8× · lower than 19% of 84
- FCF yield-15.0% · higher than 13% of 39
Peer comparison · Medical Instruments
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Stereotaxis, Inc.🇺🇸 | $92 M | — | -74.2% | +20.3% |
| Intuitive Surgical, Inc.🇺🇸 | $155.6 B | 52.6× | 25.5% | +20.5% |
| EssilorLuxottica S.A.🇫🇷 | $88.0 B | 32.1× | 8.1% | +4.5% |
| HOYA Corporation🇯🇵 | $56.2 B | 32.8× | 25.4% | — |
| Becton, Dickinson and Company🇺🇸 | $54.0 B | 57.4× | 4.2% | +8.2% |
| Alcon Inc.🇨🇭 | $37.1 B | 37.9× | 9.4% | +4.9% |
| ResMed Inc.🇺🇸 | $35.3 B | 22.1× | 27.8% | +9.8% |
| West Pharmaceutical Services, Inc.🇺🇸 | $27.1 B | 42.4× | 18.8% | +6.3% |
| Terumo Corporation🇯🇵 | $24.9 B | 27.0× | 12.0% | — |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Oct 30, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As of December 31, 2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report, GLEIF register; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Stereotaxis, Inc.? Verify and update this profile — free
Show Stereotaxis, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.